Anapharm is the Canadian subsidiary of PharmaNet Development Group, Inc., a global drug development services company who provides a wide range of early-phase drug development services to the pharmaceutical, biopharmaceutical and generic drug industries. We offer high quality services in Phase 1, bioequivalence, clinical pharmacology, regulatory affairs and a vast array of bioanalytical laboratory services. This is how we contribute to bringing to market, quality medicines around the world.